Transmembrane proteins of the tight junctions at the blood-brain barrier: structural and functional aspects.

The blood-brain barrier (BBB) is formed by microvascular endothelial cells sealed by tetraspanning tight junction (TJ) proteins, such as claudins and TAMPs (TJ-associated marvel proteins, occludin and tricellulin). Claudins are the major components of the TJs. At the BBB, claudin-5 dominates the TJs by preventing the paracellular permeation of small molecules. On the other hand, TAMPs regulate the structure and function of the TJs; tricellulin may tighten the barrier for large molecules. This review aims at integrating and summarizing the most relevant and recent work on how the BBB is influenced by claudin-1, -3, -5, -12 and the TAMPs occludin and tricellulin, all of which are four-transmembrane TJ proteins. The exact functions of claudin-1, -3, -12 and TAMPs at this barrier still need to be elucidated.

[1]  O. Nureki,et al.  Crystal Structure of a Claudin Provides Insight into the Architecture of Tight Junctions , 2014, Science.

[2]  Tetsuo Noda,et al.  Claudin-based tight junctions are crucial for the mammalian epidermal barrier , 2002, The Journal of cell biology.

[3]  D. Antonetti,et al.  Ischemia–Reperfusion Injury Induces Occludin Phosphorylation/Ubiquitination and Retinal Vascular Permeability in a VEGFR-2-Dependent Manner , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  W. Risau,et al.  Development of blood-brain barrier tight junctions in the rat cortex. , 1996, Brain research. Developmental brain research.

[5]  P. Couraud,et al.  Guanine Nucleotide-Binding Protein Gαi2: A New Partner of Claudin-5 that Regulates Tight Junction Integrity in Human Brain Endothelial Cells , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  S. Milatz,et al.  Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. , 2010, Biochimica et biophysica acta.

[7]  D. Ray,et al.  Partial recovery of the damaged rat blood–brain barrier is mediated by adherens junction complexes, extracellular matrix remodeling and macrophage infiltration following focal astrocyte loss , 2013, Neuroscience.

[8]  M. Osanai,et al.  Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. , 2008, Molecular biology of the cell.

[9]  I. Blasig,et al.  The Tight Junction Protein Occludin and the Adherens Junction Protein α-Catenin Share a Common Interaction Mechanism with ZO-1* , 2005, Journal of Biological Chemistry.

[10]  E. Sokal,et al.  Neonatal Ichthyosis and Sclerosing Cholangitis Syndrome: Extremely Variable Liver Disease Severity From Claudin-1 Deficiency , 2011, Journal of pediatric gastroenterology and nutrition.

[11]  A. Weeraratna,et al.  PKC and PKA Phosphorylation Affect the Subcellular Localization of Claudin-1 in Melanoma Cells , 2009, International journal of medical sciences.

[12]  G. Reynolds,et al.  Hepatitis C virus infects the endothelial cells of the blood-brain barrier. , 2012, Gastroenterology.

[13]  D. Stein,et al.  Progesterone Attenuates Hemorrhagic Transformation after Delayed tPA Treatment in an Experimental Model of Stroke in Rats: Involvement of the VEGF–MMP Pathway , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  H. Galla,et al.  Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions , 2010, Brain Research.

[15]  Takashi Suzuki,et al.  Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors , 2011, Journal of neurochemistry.

[16]  A. Mercer,et al.  Inhibition of Glycogen Synthase Kinase 3β Promotes Tight Junction Stability in Brain Endothelial Cells by Half-Life Extension of Occludin and Claudin-5 , 2013, PloS one.

[17]  L. Fenart,et al.  Mouse syngenic in vitro blood–brain barrier model: a new tool to examine inflammatory events in cerebral endothelium , 2005, Laboratory Investigation.

[18]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  T. Terasaki,et al.  Exogenous expression of claudin‐5 induces barrier properties in cultured rat brain capillary endothelial cells , 2007, Journal of cellular physiology.

[20]  S. Tsukita,et al.  Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells , 2005, The Journal of cell biology.

[21]  C. Dijkstra,et al.  The FASEB Journal • FJ Express Full-Length Article Diapedesis of , 2022 .

[22]  I. Blasig,et al.  CK2-dependent phosphorylation of occludin regulates the interaction with ZO-proteins and tight junction integrity , 2013, Cell Communication and Signaling.

[23]  E. Schneeberger,et al.  Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells. , 2000, Journal of cell science.

[24]  M. Furuse,et al.  Localization of angulin-1/LSR and tricellulin at tricellular contacts of brain and retinal endothelial cells in vivo. , 2014, Cell structure and function.

[25]  A. Butt,et al.  Role of post translational modifications and novel crosstalk between phosphorylation and O-beta-GlcNAc modifications in human claudin-1, -3 and -4 , 2011, Molecular Biology Reports.

[26]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[27]  K. Fujimoto,et al.  A Single Gene Product, Claudin-1 or -2, Reconstitutes Tight Junction Strands and Recruits Occludin in Fibroblasts , 1998, The Journal of cell biology.

[28]  T. Yamashita,et al.  Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. , 2003, Experimental cell research.

[29]  K. Plate,et al.  Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.

[30]  K. Hayashi,et al.  Adrenomedullin Improves the Blood–Brain Barrier Function Through the Expression of Claudin-5 , 2006, Cellular and Molecular Neurobiology.

[31]  Yanshu Zhang,et al.  The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat. , 2010, Journal of Alzheimer's disease : JAD.

[32]  H. Wolburg,et al.  Highly conserved cysteines are involved in the oligomerization of occludin-redox dependency of the second extracellular loop. , 2014, Antioxidants & redox signaling.

[33]  T. Yamashita,et al.  Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. , 2004, Experimental cell research.

[34]  D. Hermann,et al.  Liver X Receptor Activation Enhances Blood–Brain Barrier Integrity in the Ischemic Brain and Increases the Abundance of ATP‐Binding Cassette Transporters ABCB1 and ABCC1 on Brain Capillary Cells , 2012, Brain pathology.

[35]  I. Blasig,et al.  Redox-sensitive structure and function of the first extracellular loop of the cell-cell contact protein claudin-1: lessons from molecular structure to animals. , 2015, Antioxidants & redox signaling.

[36]  M. Furuse,et al.  Analysis of the ‘angulin’ proteins LSR, ILDR1 and ILDR2 – tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis , 2013, Journal of Cell Science.

[37]  H. H. Marti,et al.  Matrix Metalloproteinase-9 Mediates Hypoxia-Induced Vascular Leakage in the Brain via Tight Junction Rearrangement , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  P. Couraud,et al.  Expression and localization of claudins-3 and -12 in transformed human brain endothelium , 2012, Fluids and Barriers of the CNS.

[39]  S. Tsukita,et al.  Manner of Interaction of Heterogeneous Claudin Species within and between Tight Junction Strands , 1999, The Journal of cell biology.

[40]  S. Tsukita,et al.  Endothelial Claudin , 1999, The Journal of cell biology.

[41]  Kyle J Hewitt,et al.  The claudin gene family: expression in normal and neoplastic tissues , 2006, BMC Cancer.

[42]  B. Wiesner,et al.  Formation of tight junction: determinants of homophilic interaction between classic claudins , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[43]  T. Terasaki,et al.  mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting , 2007, Journal of neurochemistry.

[44]  J. Ghersi-Egea,et al.  Complexity and developmental changes in the expression pattern of claudins at the blood–CSF barrier , 2012, Histochemistry and Cell Biology.

[45]  M. Bewley,et al.  The occludin and ZO-1 complex, defined by small angle X-ray scattering and NMR, has implications for modulating tight junction permeability , 2012, Proceedings of the National Academy of Sciences.

[46]  W. Risau,et al.  Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.

[47]  T. Nishioku,et al.  Paracellular barrier and tight junction protein expression in the immortalized brain endothelial cell lines bEND.3, bEND.5 and mouse brain endothelial cell 4. , 2013, Biological & pharmaceutical bulletin.

[48]  Suresh Poosala,et al.  Age-related changes of claudin expression in mouse liver, kidney, and pancreas. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[49]  I. Wada,et al.  Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. , 2003, Experimental cell research.

[50]  S. Malaeb,et al.  Maternal glucocorticoid exposure alters tight junction protein expression in the brain of fetal sheep. , 2010, American journal of physiology. Heart and circulatory physiology.

[51]  H. Wolburg,et al.  Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules , 2010, Cellular and Molecular Life Sciences.

[52]  A. Lavie,et al.  Structure of the conserved cytoplasmic C-terminal domain of occludin: identification of the ZO-1 binding surface. , 2005, Journal of molecular biology.

[53]  J. Firth,et al.  Immunohistochemical localization of adherens junction components in blood-brain barrier microvessels of the rat. , 1993, Journal of cell science.

[54]  T. Terasaki,et al.  Hyperammonemia induces transport of taurine and creatine and suppresses claudin-12 gene expression in brain capillary endothelial cells in vitro , 2007, Neurochemistry International.

[55]  M. Long,et al.  Tight Junction–associated MARVEL Proteins MarvelD3, Tricellulin, and Occludin Have Distinct but Overlapping Functions , 2010, Molecular biology of the cell.

[56]  Jie Liu,et al.  Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood–Brain Barrier Damage in Early Ischemic Stroke Stage , 2012, The Journal of Neuroscience.

[57]  J. Reynolds,et al.  Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse , 2008, Brain Research.

[58]  C. Weber,et al.  Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux , 2013, Molecular biology of the cell.

[59]  A. Yu,et al.  Claudins and the modulation of tight junction permeability. , 2013, Physiological reviews.

[60]  G. Rosenberg,et al.  Matrix Metalloproteinases in Cerebrovascular Disease , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  M. Merhav,et al.  The ubiquitin–proteasome pathway regulates claudin 5 degradation , 2012, Journal of cellular biochemistry.

[62]  L. Rubin,et al.  Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.

[63]  P. Stewart,et al.  Interendothelial junctional changes underlie the developmental 'tightening' of the blood-brain barrier. , 1987, Brain research.

[64]  P. Morin,et al.  Phosphorylation of Claudin-3 at Threonine 192 by cAMP-dependent Protein Kinase Regulates Tight Junction Barrier Function in Ovarian Cancer Cells* , 2005, Journal of Biological Chemistry.

[65]  J. Piontek,et al.  Structure and function of claudins. , 2008, Biochimica et biophysica acta.

[66]  M. Gollasch,et al.  Disturbed function of the blood–cerebrospinal fluid barrier aggravates neuro-inflammation , 2014, Acta Neuropathologica.

[67]  N. Roewer,et al.  Claudin-5 as a Novel Estrogen Target in Vascular Endothelium , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[68]  S. Nishikawa,et al.  TGF-β receptor kinase inhibitor enhances growth and integrity of embryonic stem cell–derived endothelial cells , 2003, The Journal of cell biology.

[69]  B. Engelhardt,et al.  Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme , 2003, Acta Neuropathologica.

[70]  B. Engelhardt,et al.  Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts , 2004, Cell and Tissue Research.

[71]  I. Blasig,et al.  Sodium caprate transiently opens claudin-5-containing barriers at tight junctions of epithelial and endothelial cells. , 2012, Molecular pharmaceutics.

[72]  B. Barres,et al.  The Mouse Blood-Brain Barrier Transcriptome: A New Resource for Understanding the Development and Function of Brain Endothelial Cells , 2010, PloS one.

[73]  Manfred Kirchgessner,et al.  Visualization and Quantitative Analysis of Reconstituted Tight Junctions Using Localization Microscopy , 2012, PloS one.

[74]  I. Blasig,et al.  Occludin protein family: oxidative stress and reducing conditions. , 2011, Antioxidants & redox signaling.

[75]  H. Stolp,et al.  Functional effectiveness of the blood‐brain barrier to small water‐soluble molecules in developing and adult opossum (Monodelphis domestica) , 2006, The Journal of comparative neurology.

[76]  S. Tsukita,et al.  The E3 ubiquitin ligase LNX1p80 promotes the removal of claudins from tight junctions in MDCK cells , 2009, Journal of Cell Science.

[77]  H. Kumura,et al.  Distinct behavior of claudin-3 and -4 around lactation period in mammary alveolus in mice , 2011, Histochemistry and Cell Biology.

[78]  J. Leers,et al.  Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific , 2006, The Journal of physiology.

[79]  T. Joh,et al.  Oxidative stress induces gastric epithelial permeability through claudin-3. , 2008, Biochemical and biophysical research communications.

[80]  R. Kucherlapati,et al.  Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome. , 1997, Genomics.

[81]  M. Cromwell,et al.  The Coiled-coil Domain of Occludin Can Act to Organize Structural and Functional Elements of the Epithelial Tight Junction* , 2000, The Journal of Biological Chemistry.

[82]  T. Inai,et al.  The protoplasmic or exoplasmic face association of tight junction particles cannot predict paracellular permeability or heterotypic claudin compatibility. , 2010, European journal of cell biology.

[83]  Amy E. Cox,et al.  Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element. , 2008, Experimental eye research.

[84]  H. Wolburg,et al.  In tight junctions, claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization , 2013, Journal of Cell Science.

[85]  T. Terasaki,et al.  A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro , 2004, Journal of neurochemistry.

[86]  C. V. Van Itallie,et al.  Occludin is required for cytokine-induced regulation of tight junction barriers , 2010, Journal of Cell Science.

[87]  M. Ueno Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. , 2007, Current medicinal chemistry.

[88]  T. Terasaki,et al.  Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. , 2011, Journal of pharmaceutical sciences.

[89]  M. Buttmann,et al.  Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration , 2007, Journal of neurochemistry.

[90]  Stanley E. Lazic,et al.  Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models , 2012, PloS one.

[91]  Caleb F. Davis,et al.  The α-Amino-3-hydroxyl-5-methyl-4-isoxazolepropionate Receptor Trafficking Regulator “Stargazin” Is Related to the Claudin Family of Proteins by Its Ability to Mediate Cell-Cell Adhesion* , 2005, Journal of Biological Chemistry.

[92]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[93]  S. Hassan,et al.  Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation , 2011, Virology Journal.

[94]  T. Terasaki,et al.  A functional in vitro model of rat blood–brain barrier for molecular analysis of efflux transporters , 2007, Brain Research.

[95]  T. Inai,et al.  Claudin-1 contributes to the epithelial barrier function in MDCK cells. , 1999, European journal of cell biology.

[96]  S. Milatz,et al.  Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. , 2009, Molecular biology of the cell.

[97]  Howard S. Fox,et al.  Selective Decrease in Paracellular Conductance of Tight Junctions: Role of the First Extracellular Domain of Claudin-5 , 2004, Molecular and Cellular Biology.

[98]  Nathalie Arbour,et al.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.

[99]  H. Sasaki,et al.  LSR defines cell corners for tricellular tight junction formation in epithelial cells , 2011, Journal of Cell Science.

[100]  S. Tsukita,et al.  Loss of occludin affects tricellular localization of tricellulin. , 2008, Molecular biology of the cell.

[101]  K. Fujimoto,et al.  Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[102]  T. Terasaki,et al.  Fluids and Barriers of the Cns , 2022 .

[103]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[104]  R. Fernandes,et al.  Regulation of claudins in blood-tissue barriers under physiological and pathological states , 2013, Tissue barriers.

[105]  C. White,et al.  Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex , 2002, The Journal of cell biology.

[106]  J. Katahira,et al.  Clostridium perfringens Enterotoxin Utilizes Two Structurally Related Membrane Proteins as Functional Receptors in Vivo * , 1997, The Journal of Biological Chemistry.

[107]  G. Palade,et al.  JUNCTIONAL COMPLEXES IN VARIOUS EPITHELIA , 1963, The Journal of cell biology.

[108]  Kazushi Fujimoto,et al.  Claudin-1 and -2: Novel Integral Membrane Proteins Localizing at Tight Junctions with No Sequence Similarity to Occludin , 1998, The Journal of cell biology.

[109]  K. Gaus,et al.  The MARVEL transmembrane motif of occludin mediates oligomerization and targeting to the basolateral surface in epithelia , 2012, Journal of Cell Science.

[110]  Y. Yonekawa,et al.  Endothelial Cell Barrier Impairment Induced by Glioblastomas and Transforming Growth Factor &bgr;2 Involves Matrix Metalloproteinases and Tight Junction Proteins , 2008, Journal of neuropathology and experimental neurology.

[111]  Yi-Sook Jung,et al.  Role of PKCβII and PKCδ in blood–brain barrier permeability during aglycemic hypoxia , 2010, Neuroscience Letters.

[112]  J. Inazawa,et al.  Mammalian occludin in epithelial cells: its expression and subcellular distribution. , 1997, European journal of cell biology.

[113]  O. Makeyev,et al.  Ischemia–reperfusion impairs blood–brain barrier function and alters tight junction protein expression in the ovine fetus , 2012, Neuroscience.

[114]  N J Abbott,et al.  Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study. , 1990, The Journal of physiology.

[115]  T. Terasaki,et al.  Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset. , 2013, Journal of pharmaceutical sciences.

[116]  Max J. Dörfel,et al.  Modulation of Tight Junction Structure and Function by Kinases and Phosphatases Targeting Occludin , 2012, Journal of biomedicine & biotechnology.

[117]  H. Wolburg,et al.  Establishment of a neuroepithelial barrier by Claudin5a is essential for zebrafish brain ventricular lumen expansion , 2010, Proceedings of the National Academy of Sciences.

[118]  M. Balda,et al.  Identification of MarvelD3 as a tight junction-associated transmembrane protein of the occludin family , 2009, BMC Cell Biology.

[119]  B. Engelhardt,et al.  Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis , 2011, Acta Neuropathologica.

[120]  Christie P. Thomas,et al.  Nedd4‐2 interacts with occludin to inhibit tight junction formation and enhance paracellular conductance in collecting duct epithelia , 2010, American journal of physiology. Renal physiology.

[121]  F. Orsenigo,et al.  Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5 , 2008, Nature Cell Biology.

[122]  N. Ohashi,et al.  Occludin is regulated by epidermal growth factor receptor activation in brain endothelial cells and brains of mice with acute liver failure , 2011, Hepatology.

[123]  A. Traweger,et al.  The Tight Junction-specific Protein Occludin Is a Functional Target of the E3 Ubiquitin-protein Ligase Itch* , 2002, The Journal of Biological Chemistry.

[124]  H. Rahn,et al.  Elucidating the principles of the molecular organization of heteropolymeric tight junction strands , 2011, Cellular and Molecular Life Sciences.

[125]  S. Liebner,et al.  Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme , 2000, Acta Neuropathologica.

[126]  B. An,et al.  Tissue-specific expression of occludin, zona occludens-1, and junction adhesion molecule A in the duodenum, ileum, colon, kidney, liver, lung, brain, and skeletal muscle of C57BL mice. , 2013, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[127]  C. Catania,et al.  Neurons and ECM regulate occludin localization in brain endothelial cells , 2000, Neuroreport.

[128]  T. Noda,et al.  Complex phenotype of mice lacking occludin, a component of tight junction strands. , 2000, Molecular biology of the cell.

[129]  C. Thiele,et al.  Cholesterol depletion alters detergent-specific solubility profiles of selected tight junction proteins and the phosphorylation of occludin. , 2007, Experimental cell research.

[130]  K. Kim,et al.  Tricellulin expression in brain endothelial and neural cells , 2012, Cell and Tissue Research.

[131]  P. Titchenell,et al.  Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunction. , 2012, The Biochemical journal.